跳至主要内容
临床试验/IRCT20200417047113N1
IRCT20200417047113N1招募中1 期

Evaluating the safety and efficacy of allogeneic NK cells on COVID-19 induced pneumonia, double blind, randomized clinical trial

Middle East Gene Therapy corporation0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • All COVID-19 patients confirmed by CT scan with possitive RT-PCR

排除标准

  • Pregnancy or breastfeeding
  • Known HIV, HBV or HCV infection
  • Patients with malignant tumor, other serious systemic diseases and psychosis
  • Diabetic patients
  • Patients who are participating in other clinical trials

研究者

发起方
Middle East Gene Therapy corporation

相似试验